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Expression of the Xenopus homolog of the mammalian transcription factor AP-2 (XAP-2) is activated throughout the
animal hemisphere shortly after the midblastula transition, and becomes restricted to prospective epidermis by the end of
gastrulation, under the control of BMP signal modulation. Elevated expression in the future neural crest region begins at this
time. Ectopic expression of XAP-2 can restore transcription of epidermal genes in neuralized ectoderm, both in ectodermal
explants and in the intact embryo. Likewise, loss of XAP-2 function, accomplished by injection of antisense oligonucleo-
tides or by overexpression of antimorphic XAP-2 derivatives, leads to loss of epidermal and gain of neural gene expression.
These treatments also result in gastrulation failure. Thus, AP-2 is a critical regulator of ectodermal determination that is
required for normal epidermal development and morphogenesis in the frog embryo. © 2002 Elsevier Science (USA)
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The ancestral form of the transcription factor AP-2 pre-
sumably arose early in animal evolution, because recogniz-
able homologs are now present in vertebrate and insect
phyla (Bauer et al., 1998; Monge and Mitchell, 1998).
Homologs have not been reported in yeast or plant ge-
nomes. In mammals, there are three unlinked AP-2 genes,
AP-2 (the originally identified gene; Mitchell et al., 1987),
AP-2 (Moser et al., 1995) and AP-2 (initially named AP2.2
in mouse; Chazaud et al., 1996). These share extensive
protein sequence identity (70% -, 60% -, and 57% -
for mouse), with higher conservation in the activation,
DNA binding and protein dimerization domains
(Wankhade et al., 2000; Williams and Tjian, 1991a,b). A
range of potential regulatory target genes have been identi-
fied for AP-2, most—but not all—of which appear to re-
spond in a positive manner to this factor (Hilger-Eversheim
et al., 2000). Among these putative targets are several genes
specifically expressed in epidermal cells, including some
encoding epidermal keratins (Sinha et al., 2000). Promoter
element mapping experiments conducted in our laboratory
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136using transient DNA expression assays in Xenopus em-
bryos lead to the conclusion that an AP-2 protein closely
related to AP-2 was an essential factor in the ectoderm-
specific expression of the XK81A1 gene, which encodes an
embryonic type I keratin that is an early marker for ventral/
epidermal specification in this species (Jonas et al., 1985;
Snape et al., 1991; Winning et al., 1991). More recently, in
situ hybridization of AP-2 probes to mutant and wild-type
zebrafish embryos showed that this gene is ventrally ex-
pressed in early fish embryos, and regulated by the bone
morphogenetic protein (BMP) signal modulation pathway
(Nguyen et al., 1998). The earliest reported expression of
AP-2 in mammalian embryos is in extraembryonic cell
types, which have no direct equivalent in frog or fish em-
bryos (Mitchell et al., 1991), and gene targeting experiments
in mouse have not revealed developmental functions before
neurulation for AP-2 or AP-2 genes (Hilger-Eversheim et
al., 2000). However, the studies in fish and frogs suggested
that AP-2 could potentially mediate downstream effects of
BMP signaling in gastrula stages. In Xenopus embryonic
ectoderm, disruption of BMP signaling results in the trans-
fating of cells otherwise destined to be epidermis into an-
terior neural plate tissue (Sasai, 2001). BMP antagonists
secreted by cells in the organizer region are thought to
function as neural inducers via this mechanism in amphib-
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ians (Harland, 2000), while a somewhat different situation
obtains in amniote embryos (Streit and Stern, 1999). The
partitioning of ectoderm into its principal derivatives—
epidermis, neural plate and neural crest—is an important
aspect of early development, and the regulatory factors that
mediate the attendant changes in structural gene activity
are of considerable interest. We have examined the regula-
tion and function of AP-2 in ectodermal differentiation in
Xenopus, and find that AP-2 expression depends on BMP
signaling, that this factor is essential for epidermis-specific




For expression of full-length XAP-2, an open reading frame (ORF)
from the original cDNA clone (Winning et al., 1991) was subcloned
by PCR as a ClaI-StuI fragment into pCTS, a derivative of pCS2
(Turner and Weintraub, 1994) containing dual SP6 and T7 promot-
ers (Feledy et al., 1999), with an optimal translation initiation
context (ATCGATAACATG; Kozak, 1987). A deletion derivative
of this plasmid, AD, was generated by PCR, using the same
vector, with two pairs of primers (Forward: TCT CAC ACC CCC
AAT CTA CCA CAT CAA CTT, Reverse: AAG TTG ATG TGG
TAG GGG GGT GTG AGA) that result in the removal of amino
acids 40–102, corresponding to the mammalian AP-2 activation
domain (Williams and Tjian, 1991a), and a construct encoding the
Drosophila engrailed repressor domain fused to the N-terminus of
AD (EnR-AD) was prepared by ligating a PCR-generated frag-
ment, with XhoI (5) and XbaI (3) restriction sites (Forward: AAA
CTC GAG CAT GGG GGA ATG GCA GGA TCG. Reverse: GCC
TCT AGA GCT TTC GGT GTT TCT CAT CTT), into ENG-
NpCS2 (a gift from D. Kessler). A fusion of XAP-2 to the
C-terminus of the ligand binding domain of human glucocorticoid
receptor (GRXAP-2) was generated by combining the XAP-2 ORF
(5 end: filled-in BamHI, 3 end: XhoI) with amino acid residues
512–778 (StuI-XhoI digestion) of the human glucocorticoid receptor
(Kolm and Sive, 1995) cloned in pCS2. For the silent point-
mutated XAP-2 used as a control in antisense experiments (XAP-
2*), substitutions were made by PCR, changing 281-
ACAGCACCCAGGT-293 to TCAACATCCTGGA. This alters
five nucleotides but does not change the amino acid sequence.
These modifications resulted in an RNA that was efficiently
translated in vitro, but no longer significantly cleaved in vitro or in
vivo by combined activities of ASO281 and RnaseH (data not
shown). All PCR-generated constructs were verified by DNA
sequence analysis.
Embryo Manipulation and in Situ Hybridization
Embryos were obtained from adult Xenopus laevis by hormone-
induced egg laying and artificial fertilization using standard meth-
ods, and staged according to Nieuwkoop and Faber (1967). Full-
length capped transcripts encoding chordin, XAP-2, XAP-2*, EnR-
AD, GRXAP-2, type I keratin XK81 and type II keratin XK76 were
generated using an SP6 mMessage Machine kit (Ambion Inc,
Austin, TX). All synthetic mRNAs were checked for size by
denaturing agarose gel electrophoresis, and tested and determined
to be approximately equally efficient templates for protein synthe-
sis as shown by in vitro translation using a rabbit reticulocyte kit
from Promega (Madison, WI; data not shown). Following microin-
jection, embryos were cultured in 3% Ficoll-400/1X MMR until
sibling embryos reached stage 7. For ectodermal explants, approxi-
mately 2/3 of the pigmented ectoderm was dissected from stage
7–8 embryos and cultured in 0.3X MMR until sibling embryos
reached the desired stage. Embryos were dissociated with calcium,
magnesium-free medium as described previously (Sargent et al.,
1986). For experiments with GRXAP-2, fertilized eggs injected with
RNAs encoding chordin (500 pg) and GRXAP-2 (1 ng) were treated
with 10 g/ml cycloheximide and 10 m dexamethasone as de-
scribed by Gammill and Sive (1997).
Whole-mount in situ hybridization was carried out according to
Harland (1991), with some modifications (Luo et al., 2001). Anti-
sense probes labeled with digoxigenin or fluorescein were synthe-
sized using an in vitro transcription kit (Roche Diagnostics, Indi-
anapolis, IN). For double in situs, digoxigenin-labeled XAP-2 probe
was stained with BM-purple (Roche Diagnostics, Indianapolis, IN),
and fluorescein-labeled chordin probe with Magenta-Phos (5-
bromo-6-chloro-3-indolyl-phosphate 4-toluidine salt; Biosynth In-
ternational Inc., Naperville, IL).
Northern and Southern Blots
RNAs were analyzed using denaturing methylmercury hydrox-
ide RNA gels as described previously (Sargent et al., 1986). North-
ern blots were washed in 0.2X SSPE at 65°C. Probes for XK81 (Jonas
et al., 1985), XK76 (Jamrich et al., 1987), Dlx3 (Feledy et al., 1999),
Dlx5 (Luo et al., 2001), Msx1 (Su et al., 1991), Otx2 (Pannese et al.,
1995), Zic-r1 (Mizuseki et al., 1998), Zic3 (Nakata et al., 1997), and
EF1 (Krieg et al., 1989) were labeled with 32P-dCTP by primer
extension (Life Technologies, Inc., Gaithersburg, MD).
Antisense Oligonucleotide Injections
Two different approaches to antisense oligonucleotide inhibition
were attempted. Initial attempts used morpholino oligonucleotides
(GeneTools, Corvallis, OR). Embryos injected with these oligonu-
cleotides showed none of the characteristic molecular or pheno-
typic defects we observed using dominant negative AP-2 mRNA
injections. A second approach used antisense oligonucleotides
where many of the bridging phosphodiester linkages were modified
with diethylethylenediamine (Dagle et al., 2000). The target site in
the AP-2 mRNA was selected in a two step process. The optimal
folding of the AP-2 mRNA sequence was determined using the
mFold algorithm of M. Zuker (http://bioinfo.math.rpi.edu/
mfold/rna/form1.cgi; Zuker et al., 1999; Mathews et al., 1999).
Four different sites were selected for testing, including one site that
spanned the translational start site, one all loop, one including a
loop and an adjacent stem, and one all stem site. Unmodified
oligonucleotides complementary to the selected sites were injected
into fertilized eggs that has been previously injected with in vitro
synthesized AP-2 mRNA. In this assay, the efficiency of oligonu-
cleotide mediated cleavage of the AP-2 mRNA ranged from nearly
complete (with target sites predicted to have all loop or loop and an
adjacent stem) to moderate (all stem target site) to nearly none (the
AUG region of the mRNA). We note that comparing these data, and
target site selection screening of other mRNAs we have analyzed
have not yet found a strong correlation between predicted structure
and efficacy of target site. One of the better sites, starting at
position 281 was used to design the following antisense oligo: G 
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CC  AA  CCTGGGT  GC  TG  T, with “”
representing diethylethylenediamine modified linkages leaving the
middle six linkages unmodified. A similar oligonucleotide, with
only three phosphodiester linkages was used as an injection control
and was unable to mediate AP-2 mRNA degradation and had no
effect when injected into embryos (data not shown).
RESULTS
Early Expression of AP-2 in Xenopus
Of the three mammalian AP-2 genes, AP-2 is the most
homologous to XAP-2 (92% identity vs. 67% for  and 58%
for ). Using low-stringency Southern and Northern blot
analysis with murine AP-2 probes we determined that
while there is some evidence for sequences corresponding
to  and  AP-2 isoforms in the Xenopus genome, only
AP-2 transcripts could be detected through tailbud stages
(data not shown). Consequently analysis of AP-2 function
in Xenopus development, at least at early stages, may be
limited to a single gene (i.e. XAP-2).
The XAP-2 gene has been previously shown by Northern
blot analysis to be expressed in the early embryonic ecto-
derm (Winning et al., 1991), and by whole-mount in situ
hybridization studies to be active in early ventral ectoderm,
and dependent upon bmp2b/swirl gene function in zebra-
fish (Nguyen et al., 1998). Fig. 1 shows whole-mount in situ
hybridizations of Xenopus AP-2 (XAP-2) probes to early and
late gastrula stage frog embryos. XAP-2 RNA is readily
detectable by this method at the beginning of gastrulation
and is present throughout the ectoderm. By late gastrula
(Fig. 1B) XAP-2 RNA has been cleared from prospective
neural plate, and is just beginning to accumulate in areas
corresponding to future neural crest cells.
The spatiotemporal expression pattern of XAP-2 sug-
gested that as in zebrafish, this gene is a target of BMP
signaling in the Xenopus embryo. To test this, ectoderm
was explanted from embryos injected with RNA encoding
the BMP antagonist chordin (Sasai et al., 1994). XAP-2
expression in ectoderm isolated from such embryos was
strongly inhibited, supporting the conclusion that at the
earliest stages, this gene depends on BMP signaling in
Xenopus (Fig. 2A). Several ventrally expressed genes have
been shown to similarly depend on BMP in this organism.
Some, such as Msx1 (Suzuki et al., 1997) and XOM/
XVENT2 (Trindade et al., 1999) can be activated by BMP in
the absence of protein synthesis, and have thus been con-
sidered to represent an “immediate early” response to BMP
in this context. Other genes, including Dlx3 (Feledy et al.,
1999) and Dlx5 (Luo et al., 2001) also require BMP signals
for expression, but will not respond to BMP treatment in
the presence of cycloheximide, indicating a requirement for
other zygotically supplied factors. As shown in Fig. 2B,
XAP-2 falls into this latter category. In this experiment,
embryos were cultured and dissociated in medium lacking
divalent cations, a procedure that inhibits signaling by
endogenous factors including BMPs (Sargent et al., 1986;
Wilson and Hemmati-Brivanlou, 1995). This procedure pre-
vents activation of AP-2, which can be restored by adding
recombinant BMP-4 to the medium. However, this recovery
is blocked by prior addition of cycloheximide, whereas
activation of Msx1, which behaves as an immediate early
response, is not prevented.
XAP-2 Directly Controls Keratin Gene Expression
In an earlier study from this laboratory (Snape et al.,
1991), expression of an epidermal type I keratin gene (XK81;
Jonas et al., 1985) in transient DNA injection experiments
was shown to depend upon a specific AP-2 binding site
located at 157 in the XK81 promoter region. However, the
ability of this factor to regulate the endogenous XK81 gene,
or other epidermal genes, has not been directly assessed. To
examine this question, we carried out rescue experiments
in which epidermal fate was suppressed in ectodermal
explants by injection of chordin RNA, and co-injection of
XAP-2 RNA was tested for its ability to restore epidermal
gene expression. As shown in Fig. 3, under conditions in
which BMP signaling is strongly suppressed (Luo et al.,
2001) XAP-2 is able to activate expression of at least two
keratin genes, XK81 and XK76, a type II epidermal keratin
essentially identical to XlKERB2 (Genbank Accession
X02895; Hoffmann et al., 1985). An epidermal homeodo-
main gene, Dlx5, was also activated. The degree of activa-
tion varied, but in no case was expression returned to
control levels. In contrast, the homeodomain gene Msx1
was not detectably reactivated by XAP-2 overexpression in
these assays. Nor were neural plate marker genes, such as
Zic-r1 (Mizuseki et al., 1998), repressed. Similar results
were obtained with intact embryos by ectopic overexpres-
sion of XAP-2 in the neural plate (data not shown).
The presence of a binding site for AP-2 in the XK81
promoter region (Snape et al., 1990, 1991), in conjunction
FIG. 1. Early expression of XAP-2. Whole mount in situ hybrid-
izations at stage 10.25 (A) and stage 12.5–13 (B) to antisense XAP-2
probe, stained with BM-purple. In panel A, the arrowhead indicates
hybridization to a chordin probe to mark the dorsal lip (magenta-
phos stain). At the beginning of gastrulation, XAP-2 RNA was
found throughout the ectoderm, then becomes excluded from the
neural plate by the end of gastrulation, at which time high level
expression commences in the cranial neural crest region.
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with the results just described, supports a direct physical
interaction between XAP-2 and the XK81 gene. Such direct
interaction can be demonstrated by using an inducible
fusion protein comprising XAP-2 and the ligand binding
region of the human glucocorticoid receptor protein (Kolm
and Sive, 1995), in conjunction with cycloheximide treat-
ment to preclude postactivation protein synthesis. The
results of such an experiment are shown in Fig. 4A. Fertil-
ized eggs were injected with RNAs encoding chordin, to
inhibit keratin gene expression, and the GRXAP-2 fusion.
Ectodermal explants were removed at mid to late blastula,
then divided into two groups, one of which was incubated
in 10 g/ml cycloheximide, which inhibits at least 95% of
protein synthesis (Suzuki et al., 1997; data not shown).
Subsequently, each group was split again, and half treated
with 10 m dexamethasone (DEX) to activate the GRXAP-2
factor. Following culture to the equivalent of stage 12
(mid/late gastrula), RNA was isolated and analyzed by
northern blotting. Keratin gene XK81 was clearly activated
in a DEX-dependent manner, in the presence or absence of
cycloheximide. As a control for general metabolic inhibi-
tion due to the protein synthesis blockade, XK81 gene
activation was normalized to the expression of the transla-
tional elongation factor gene EF1, and the result of this
calculation is shown in Fig. 4B. After making this correc-
tion, the activation of XK81 by XAP-2 is comparable in
magnitude with or without protein synthesis following
induction by DEX. Therefore we conclude that XAP-2 binds
directly to the XK81 gene in vivo, resulting in its transcrip-
tion in epidermal cells.
Embryonic ectoderm is receptive to numerous inductive
signals during gastrulation. This receptiveness is not con-
stant with time, however, such that by the end of gastrula-
tion, ectoderm is no longer competent to respond to meso-
dermal or neural induction (Servetnick and Grainger, 1991).
To determine if the XK81 gene exhibits time-dependent
changes in sensitivity to XAP-2, another experiment using
FIG. 2. BMP dependence of XAP-2 expression. (A) Effect of
chordin expression. Fertilized eggs were injected with 250 pg of
RNA encoding chordin, then ectodermal explants were dissected at
stage 7/8 and cultured until sibling embryos reached late gastrula
(st12.5). RNA was extracted and probed by Northern blot using
cDNAs for XAP-2, Zic-r1, or EF1 as a control. Chordin injection
inhibited XAP-2 and simultaneously induced expression of the
neural plate marker Zic-r1. (B) Requirement for protein synthesis.
Embryos were cultured in calcium/magnesium-free medium begin-
ning at early cleavage stage (16/32-cell), and vitelline envelopes
removed to facilitate continuous dissociation and dispersion, a
procedure which blocks cell-cell communication (Sargent et al.,
1986). Dispersed cells were divided into four pools. Protein synthe-
sis was inhibited in two of the pools by treatment in 10 g/ml
cycloheximide beginning at the equivalent of stage 7/8 (CHX).
After 15 min, 50 ng/ml recombinant human BMP4 protein (Re-
search Diagnostics, Inc., Flanders, NJ) was added to two pools
(BMP), Ca2 and Mg2 restored to 1 mM each, and the cells
cultured until stage 11. RNA was prepared and analyzed by
Northern blot, using probes for XAP-2, Dlx3, Msx1, and EF1 as a
control for general inhibition of protein synthesis by the CHX
treatment. XAP-2 RNA induction by BMP was inhibited by CHX
treatment, indicating indirect activation by this signaling pathway.
FIG. 3. Rescue of keratin expression in neuralized ectoderm by
XAP-2. Fertilized eggs were injected with 250 pg RNA encoding
chordin, with or without 100 pg RNA encoding XAP-2. Ectodermal
explants were isolated at stage 7–8 and cultured until sibling
embryos reached stage 13, then samples were processed for North-
ern blot analysis. Probes were for type I (XK81) and type II (XK76)
embryo-specific epidermal keratins, two epidermal homeodomain
genes, Dlx5 and Msx1, and neural-plate (Zic-r1) or EF1. Chordin
strongly inhibited all epidermal gene expression. The keratin genes
and Dlx5 were partially restored by addition of XAP-2 RNA. Msx1,
however, was not activated, nor was repression of Zic-r1 observed.
Note that under these conditions endogenous XAP-2 expression
was inhibited, as shown in Fig. 2A and B.
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the GRXAP-2 was carried out. In this case, embryos were
injected with RNAs encoding chordin and this fusion
protein, ectodermal explants excised at blastula stages, and
then treated with DEX beginning at different times ranging
FIG. 4. The XK81 gene is a direct target for XAP-2. (A) Fertilized
eggs were injected with a mixture of RNAs encoding chordin (500
pg) and glucocorticoid-inducible GRXAP-2 (1 ng). Ectodermal ex-
plants were isolated at stage 7–8, and divided into four groups. Two
groups were treated with 10 g/ml cycloheximide (CHX) to
inhibit protein synthesis. After 15 min, two groups (DEX) were
treated with 10 M dexamethasone (DEX) to activate the accumu-
lated GRXAP-2 fusion protein. Controls were treated with an
equivalent volume of the DEX solvent (ethanol) alone. After
culturing to stage 12 equivalent, RNA was isolated and processed
for Northern blot analysis. (A) Hybridization to the XK81 keratin
probe revealed that the GRXAP-2 fusion protein responded as
expected to the DEX administration, resulting in partial recovery of
XK81 expression (DEX vs. DEX-), and that this was not prevented
by cycloheximide (CHX  vs. CHX-). Note that different exposures
are shown for XK81 and EF1 probes. (B) Since cycloheximide
treatment has a general inhibitory effect on RNA synthesis in
Xenopus embryos, phosphorimage analysis was performed to nor-
malize the XK81 expression data to that of the control, EF1, and
the results shown in histogram format. Based on this analysis,
induction of XK81 by XAP-2 appeared to have a similar magnitude
in the presence or absence of cycloheximide. (C, D) Loss of
competence during gastrulation. Fertilized eggs were injected with
a mixture of chordin and GRXAP-2 RNAs as in panel A. Ectoder-
mal explants were isolated at stage 7/8, and subsets transferred to
medium containing 10 m DEX at the stages indicated, from stage
8.5 through stage 13. Following culture to the equivalent of stage
20 (to minimize the temporal variable in DEX exposure), RNA was
isolated for Northern blot analysis. Hybridization with an XK81
keratin probe revealed strong recovery of keratin expression when
DEX was added immediately (stage 8.5; note that the uninjected
lane was loaded with a 1/10 dilution to facilitate exposure), but that
this response rapidly declined for subsequent DEX additions.
Hybridization with control EF1 probe showed essentially no
differences, and hybridization with a XAP-2 probe indicated that
FIG. 5. Loss-of-function analysis; ectodermal explants. Embryos
at the 8-cell stage were radially injected into each of the four
animal hemisphere blastomeres, with a total of 1 ng RNA encoding
an antimorphic derivative of XAP-2 bearing the repressor domain
from the Drosophila engrailed gene product (EnR-AD), or 1.2 ng of
a metabolically stable antisense oligonucleotide (ASO) with or
without co-injection of 100 pg RNA encoding silent point-mutated
XAP-2 (XAP-2*). Ectodermal explants were isolated at stage 7–8
and processed for Northern blot analysis after culture to the
equivalent of stage 12–13. Hybridization to type I (XK81) and type
II (XK76) epidermal keratin probes showed that both genes were
strongly inhibited by both treatments, whereas the control EF1
RNA was not affected. EnR-AD also repressed Dlx5, and Msx1,
homeobox genes that are specific for the epidermal portion of
ectoderm at gastrula stages, while the ASO treatment had little
effect on the two homeodomain genes. In addition, EnR-AD but
not the ASO injection resulted in activation of neural plate marker
genes such as Otx2 and Zic3. Hybridization of ASO-injected
samples with XAP-2 probe shows incomplete destruction of endog-
enous XAP-2 RNA via the antisense treatment. In the third lane
the strongly hybridizing band is due to the injected silent-mutated
XAP-2* RNA, which rescued the expression of epidermal genes to
control levels.
the injected GRXAP-2 RNA (endogenous XAP-2 hybridization not
visible at this exposure) was not differentially affected by the DEX
treatment. Phosphorimager quantification of Northern blot data
are shown in panel D.
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from the mid blastula transition (stage 8.5) to early neurula
(stage 13). Following culture in DEX to tailbud (stage 20),
RNA was isolated and analyzed by Northern blot. As shown
in Fig. 4 (panels C, D), XK81 gene expression was activated
most effectively when DEX was added at the earliest stage,
but this response declined rapidly, falling roughly twofold
by early gastrula (stage 10.25) and was essentially absent by
the end of gastrulation. This reduction was not due to
degradation of the injected AP-2 RNA; which were approxi-
mately equal in all samples, and the period allowed for
transcription of keratin RNA was long relative to the
interval between the first and last DEX addition. Therefore
the positive regulation of XK81 gene expression by XAP-2 is
under some form of inhibitory competence control that
begins to be imposed at the very beginning of gastrulation
and is essentially complete within a few hours.
XAP-2 Is Required for Epidermal Gene Expression
and Gastrulation
The data presented above support an obligatory and
positive role for XAP-2 in regulating epidermal gene expres-
sion. To further test this model, loss-of-function experi-
ments were carried out. Two different approaches were
used: Overexpression of a modified XAP-2 in which the
activation domain was replaced by a repressor domain from
the Drosophila engrailed protein (EnR-AD), and injection
of a metabolically stable antisense oligonucletide (ASO281)
that resulted in degradation of endogenous XAP-2 mRNA.
Both of these manipulations would be expected to interfere
with XAP-2 function in vivo, via different mechanisms. As
shown in Fig. 5, expression of several epidermal genes was
inhibited in animal cap experiments using these reagents.
In general, the engrailed fusion resulted in more pro-
nounced effects; both keratins and two different epidermal-
localized homeodomain factors (Dlx5 and Msx1) were re-
pressed, and there was a concomitant activation of neural
plate marker gene expression (Fig. 5, left panels). ASO281
injection resulted in significant but incomplete destruction
of endogenous XAP-2 RNA, and substantially reduced ex-
pression of epidermal keratin genes. Dlx5 and Msx1 were
not appreciably affected, however, nor were neural marker
genes activated. An important advantage of the antisense
approach is that the effect can be rescued by co-injection of
a mutated XAP-2 that is refractory to cleavage (XAP-2*),
ruling out nonspecific effects. The general conclusion from
these experiments was that XAP-2 function is required for
epidermal identity, with varying degrees of sensitivity for
different genetic targets. Complete loss of AP-2 function
resulted in neuralization, while partial loss of function had
preferential effects on targets such as keratin genes, pre-
sumably reflecting a higher sensitivity to XAP-2 levels.
To determine if loss of XAP-2 function has effects on
morphogenesis, we carried out similar experiments on
whole embryos. Embryos at the 8-cell stage were injected
radially in the animal quartet with at total of 600 pg of
ASO281, alone or combined with either 100 pg of XAP-2* as
a rescue control, or with 50 pg each of synthetic mRNAs for
XK81 and XK76, and cultured until sibling embryos had
reached stage 20. Typical results are shown in Fig. 6.
ASO281 treatment resulted in highly abnormal develop-
ment, with complete penetrance: the ectoderm collapsed
into a small sac, leaving the mesendoderm exposed in a
manner resembling exogastrulation. In contrast, co-
injection of XAP-2* resulted in a substantial rescue of
normal development, with about 1/3 of the embryos appear-
ing essentially normal, incomplete blastopore closure in
another 1/3, and gastrulation failure in the remainder (Fig.
6B). Co-injection of type I and type II keratin mRNAs had
little if any effect on the ASO phenotype, suggesting that
deficiencies in additional gene products were at least partly
involved. Similar morphological defects were obtained by
injection of EnR-AD RNA (data not shown). Based on
these results we conclude that XAP-2 function is required
FIG. 6. Loss-of-function analysis; intact embryos. Fertilized eggs
were injected with either (A) 600 pg of ASO281, (B) a mixture of 600
pg ASO281 and 100 pg of XAP-2* RNA, or (C) 600 pg ASO281 with
50 pg each XK81 and XK76, and cultured to stage 20. Control,
uninjected embryos are shown in panel D. ASO281 treatment
resulted in extensive gastrulation failure in 29/29 of the embryos,
with pigmented ectoderm collapsed into a small sac. Co-injection
of XAP-2* RNA rescued essentially normal development in about
12/31 of embryos, partially rescued another 9/31, and had little
effect on the remainder. An example of each is shown in panel B.
Keratin mRNA injection had little if effect; 24/27 were essentially
identical to embryos injected with ASO281 alone, although the
remaining three showed some a more moderate phenotype. One of
the three partially normal embryos is shown in panel C (embryo on
the right).
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for gastrulation in Xenopus, probably functioning as a
regulator of ectodermal morphogenesis.
DISCUSSION
Molecular and genetic analysis of the BMP signaling
pathway have revealed several steps in the transduction of
such signals, including complex antagonism of BMP ligand
binding, the nature of the BMP receptors, cytoplasmic
transduction by SMAD factors, and interaction with
nuclear factors (for recent reviews see Altmann and Brivan-
lou, 2001; Sasai, 2001). Some directly and indirectly respon-
sive genes have also been identified, but the transcriptional
response to BMP signaling, and how this leads to differen-
tiation of ventral cell types, is still mostly unknown. One
way to identify regulatory components of this pathway is to
perform functional mapping of the control regions of BMP-
dependent genes, and use this information to identify
transcription factors that mediate this regulation. Using
such an approach, the transcription factor AP-2 was identi-
fied as an important element in the regulation of the
XK81A1 gene, which encodes the major type I cytokeratin
expressed in embryonic Xenopus epidermis (Jonas et al.,
1985). AP-2 was subsequently shown by studies on ze-
brafish BMP signaling mutants to be under the control of
this pathway in the fish embryo (Nguyen et al., 1998), and
has been implicated in the regulation of a diverse array of
target genes, including several expressed in epidermis
(Hilger-Eversheim et al., 2000). In this report we present
evidence from gain and loss of function experiments indi-
cating that AP-2 is a critical transcriptional component of
BMP-based specification in Xenopus ectoderm.
Gene-targeted mice lacking functional AP-2 die perina-
tally with numerous morphological defects including fail-
ure of cranial, neural tube and abdominal wall closure
(Schorle et al., 1996; Zhang et al., 1996). It is possible that
the molecular basis of this phenotype is related to the
gastrulation failure we observed in Xenopus embryos with
compromised AP-2 function, perhaps reflecting a role for
this factor in regulating the shape or migration of epidermal
cells during gastrulation and neurulation. On the other
hand, the strict dependence of keratin gene expression on
XAP-2 function in the frog embryo contrasts with the
situation in the AP-2 null mouse, where, at least on the
dorsal side, stratified epidermis exhibited essentially nor-
mal histology (Talbot et al., 1999). Some alterations in
keratin gene expression in such null mice have been re-
ported (Maytin et al., 1999), but nothing as severe as the
blockade to type I and type II keratins described here. It is
possible that the differences between frog and mouse are
due in part to functional redundancy in the AP-2 gene
family, since the  and  genes, although possibly present in
the Xenopus genome, do not appear to be expressed in the
gastrula stage frog embryo. Alternatively, in view of the fact
that they are embryo-specific (Jonas et al., 1985), XK81 and
XK76 may not be true homologs of keratin genes expressed
in stratifying mouse epidermis, and therefore may be regu-
lated differently. In any case, it is clear that AP-2 is
important in development from insect to mammalian
phyla, and the direct interaction between this factor and the
XK81 keratin gene in Xenopus should provide a useful
model for other AP-2 targets, some of which may play
regulatory roles in morphogenesis.
Another interesting feature of AP-2 function in Xenopus
is the loss of competence of neuralized tissue to respond to
this factor. This competence loss is quite rapid, declining
rapidly during gastrulation. This loss suggests that some
change takes place in ectodermal cells during this interval
which prevents AP-2 from interacting with genomic target
sequences. The molecular mechanism for this inhibition is
unknown, but one possibility is that a required co-factor for
XAP-2 might decay during gastrulation, rendering the over-
expressed XAP-2 protein nonfunctional. This seems un-
likely, as XAP-2 is expressed in epidermis, as well as
numerous other tissues, throughout the life of vertebrates.
A more plausible alternative is remodeling of chromatin in
the vicinity of the XK81 gene. AP-2 has been shown to
associate with hypersensitive sites upstream from the
mammalian K14 genes (Sinha et al., 2000). Since the XK81
is closely related in sequence to mammalian K14, some-
thing similar could be taking place in Xenopus embryonic
epidermis. Developmental alterations in chromatin con-
figuration in the upstream regulatory region of the XK81
gene (Snape et al., 1990, 1991) could result in the physical
exclusion of AP-2. Xenopus ectoderm loses responsiveness
to different inducers at different times, with competence for
mesoderm induction declining first, followed by that for
neural induction (Servetnick and Grainger, 1991). It is
interesting that the initial drop in response of the epidermal
keratin gene has occurred by the earliest stage of gastrula-
tion (st. 10.25), whereas the neural induction process that
resulted in the repression of keratin remains possible until
mid/late gastrula. This suggests that epidermal repression,
possibly at a chromatin level, is among the earliest steps in
neural induction.
An argument supporting a central role for AP-2 in epider-
mis derives from the activation of neural marker genes by
EnR-AD; this neuralization is comparable to what hap-
pens when BMP signaling is disrupted, suggesting that most
of the downstream response to this inducer is dependent
upon XAP-2. It is interesting that the EnR-AD effect
includes repression of Msx1; activation of Msx1 by exog-
enous BMPs can occur in the presence of cycloheximide
added before the midblastula transition, indicating that
zygotic factors, including XAP-2, are not needed (Suzuki et
al., 1997). One model to explain the inhibition of Msx1
expression by EnR-AD suggests that XAP-2 may be nec-
essary for maintenance of the epidermal differentiated state
once this has been triggered by BMP signaling. Thus, Msx1
(and other immediate response genes) may be activated by
BMP signaling, but in the absence of XAP-2 function the
epidermal program fails, and the ectoderm reverts to ante-
rior neural fate. This interpretation would be consistent
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with the observation that ectopic XAP-2 can restore keratin
and Dlx5 gene expression in neuralized ectoderm, but not
Msx1 expression, and that this occurs without concomitant
repression of neural genes. The gastrulation failure in
embryos injected with AP-2 antagonists also implies more
global functions of AP-2 in the early embryo. While keratin
gene expression was preferentially affected by the ASO
treatment in animal cap assays, the morphological pheno-
type was probably not due simply to mechanical defects in
epidermal cells resulting from loss of the principal cytoskel-
etal proteins; injection of mRNAs encoding type I and type
II keratins failed to rescue normal development, and an
identical morphological phenotype was obtained by the
more potent antagonist EnR-AD (data not shown).
Thus, the constellation of XAP-2 target genes may encode
a range of epidermal proteins, both structural and possibly
also additional regulators, for example, factors controlling
morphogenetic movements in gastrula ectoderm. Identifi-
cation of such targets will be an important goal of future
research. It will also be very interesting to examine the role
of AP-2 in neural crest, where this factor is intensely
expressed following gastrulation. Approaches similar to
those used here may be applicable to such questions.
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